Clearbridge Health plans IPO spin-off for associate
Annabeth Leow
Singapore
CATALIST-listed medical technology company Clearbridge Health may bring an associate to an initial public offering (IPO), not long after its own bourse debut in December last year.
Clearbridge BioMedics has secured pre-IPO funding commitments of S$6.6 million from oncology professionals and healthcare and biotechnology investors, in exchange for equity, the company said on Thursday.
TRENDING NOW
Indonesia sacks Finance Minister Purbaya, replaces him with deputy Suahasil
‘Low hire, low fire’ labour market: Britain’s boomers cling to jobs as young get locked out
Singapore plays premium data centre game as Johor, Batam take on scale
CapitaLand Investment’s retrenchments: Mind the downsides of a profitable business laying off staff